Kailera Therapeutics · 7 hours ago
Senior Manager, CMC Operations
Kailera is committed to developing therapies that empower individuals to transform their lives and improve their health. The Senior Manager, CMC Operations will oversee the execution of CMC activities, manage vendor relationships, and ensure project timelines and budgets are met.
BiotechnologyPharmaceuticalTherapeutics
Responsibilities
Drive Tech Ops, Quality, and Regulatory teams to ensure project priorities are clearly documented and communicated
Manage the CMC vendors to ensure all work is occurring according to the contracted scope, schedule, and budget
Responsible for the tracking of program budget and finances for CMC functions
Create and independently maintain project communication tools, such as CMC team meeting minutes, action tracking, and timeline plans
Proactively communicate key issues and any other critical topics in a timely manner to the appropriate management level and/or to any other relevant stakeholders
Define and monitor progress on deliverables and provide timely updates to key stakeholders on project target dates and progress against goals
Actively manage relationships and communication between Kailera and external partners or service providers as required
Qualification
Required
8+ years of experience in pharmaceutical drug development and track record of success supporting multiple projects or programs simultaneously
Excellent communication/presentation skills and proficiency in Smartsheet software
Proven track record of creativity, problem solving, and productivity
Demonstrated success working in interdisciplinary and cross-functional teams
Comfortable working in a dynamic, interactive, fast-paced, and entrepreneurial environment
Bachelor's degree in a scientific discipline
Benefits
Comprehensive health coverage
Flexible time off
Paid holidays
Monthly wellness stipend
Generous 401(k) match
Tuition reimbursement
Commuter benefits
Disability and life insurance
Annual bonus opportunities
Equity grants
Company
Kailera Therapeutics
Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.
Funding
Current Stage
Growth StageTotal Funding
$1BKey Investors
Bain Capital Private Equity
2025-10-14Series B· $600M
2024-10-01Series A· $400M
Leadership Team
Recent News
2026-01-05
2025-12-24
2025-12-17
Company data provided by crunchbase